EFB Dengue Literature Review

Class Switch Recombination

13 min read

Class Switch Recombination

Overview

Class switch recombination (CSR) is a DNA recombination event in which the constant region of the immunoglobulin heavy chain is replaced, changing the antibody isotype from IgM (and IgD) to IgG, IgA, or IgE while preserving antigen specificity. CSR is catalysed by activation-induced cytidine deaminase (AID) and typically requires CD40–CD154-mediated T cell help within germinal centres. However, CD40-independent CSR has been demonstrated, particularly via BAFF/BLyS-APRIL signalling from dendritic cells, providing an extrafollicular route to isotype-switched antibodies.

Key Points from Literature

  • DN B cells contain sizable isotype-switched fractions (~44% IgG⁺, ~15% IgM⁺, and IgA⁺ cells) despite their proposed extrafollicular origin — demonstrating that CSR can occur, or its products can accumulate, outside of canonical GC reactions (see Wei2007 - DN Memory B Cells in SLE, n=29 healthy + n=36 SLE cross-sectional).

  • CD40-independent class switching via BLyS and APRIL by dendritic cells was shown by Litinskiy et al. (2002, Nat Immunol) — cited in Wei2007 - DN Memory B Cells in SLE as a mechanism by which EF B cells could acquire isotype-switched phenotypes without full GC participation.

  • The presence of IgG⁺ and IgA⁺ cells within the DN compartment is one of the features supporting their classification as memory B cells rather than simply naive cells that failed to enter GCs (see Wei2007 - DN Memory B Cells in SLE).

  • CSR in low-SHM EF-derived ASCs: Approximately 30–33% of circulating ASC sequences in SLE have <3% VH mutation, consistent with EF differentiation. These low-SHM sequences include switched isotypes (IgG + IgA = majority of ASC sequences in both SLE and vaccination). This confirms that CSR can occur concurrently with, or prior to, substantial SHM accumulation — consistent with extrafollicular CSR mechanisms (see Tipton2015 - ASC Diversity and Origin in SLE).

  • PRDM1 progressive demethylation and accessibility confirms CSR-competent state in EF precursors: RRBS shows progressive demethylation of the PRDM1 (BLIMP-1) promoter from resting naive through to DN2, and ATAC-seq shows increasing accessibility at the same locus. Since BLIMP-1 expression is required for plasma cell differentiation (which follows CSR), this progressive epigenetic opening across the aNAV→DN2 EF trajectory confirms these cells are primed for both CSR and terminal differentiation independently of GC transit (see Scharer2019 - Epigenetic Programming in SLE B Cells, RRBS + ATAC-seq, n=9 SLE + 12 HC).

  • IgG3 enrichment in DN2 cells suggests IFN-γ-driven EF class switching: DN2 cells show higher IgG3⁺ frequency than SWM or DN1 in both healthy donors and SLE. IgG3 is the isotype most strongly induced by IFN-γ in human CSR. Since the EF pathway is IFN-γ-dependent (rNAV → aNAV → DN2 driven by TLR7 + IFN-γ + IL-21), IgG3 enrichment in DN2 may directly reflect the cytokine milieu of EF differentiation — a potential EF biomarker distinct from the IgG1-dominant GC output (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, flow cytometry + in vitro differentiation).

  • CSR occurs infrequently in germinal centres: Roco et al. (2019, Immunity) demonstrated that CSR occurs infrequently within GCs, with the majority of CSR happening before GC entry. This undermines the premise that isotype-switched B cells are necessarily GC-derived (see Sanz2025 - Human Atypical B Cells Overview, review citing Roco et al. 2019).

  • Ongoing CSR observed in COVID-19 ASCs (n=1 patient — not generalizable): >3% of all ASC clonotypes from a single CoV-A patient had cellular members in both unswitched (IgM) and switched (IgG1, IgA1) compartments; 60% of the top 15 clonotypes showed contemporaneous IgM↔IgG1/IgA1 connections. This is consistent with real-time class switching within the EF-derived ASC pool during acute viral infection. Balanced IgM/IgG1/IgA1 representation with low SHM throughout suggests CSR is occurring in newly recruited, EF-derived clones. However, this derives from a single patient’s repertoire — the council rated n=1 scV(D)J data as insufficient to establish general claims about EF CSR (see Woodruff2020 - EF B Cell Responses in COVID-19, 10x Chromium scV(D)J, Circos analysis, n=1 patient).

  • DENV-specific class-switched MBCs accumulate with repeat exposure: DENV-specific IgD⁻ class-switched MBCs were significantly higher in 2° than 1° dengue (median 105 vs 53 per 10,000; p<0.001), and DENV-specific IgG+ MBCs similarly elevated (median 84 vs 43; p<0.001). At 18M, IgD⁻/IgM⁻/IgG⁻ MBCs (likely IgA+) trended higher in 2° immunity (p=0.1). Naïve-like IgD+/IgM+ DENV-specific cells — which have not undergone CSR — persisted but diminished with multiple exposures (14% vs 8% of DENV-specific B cells at 18M after 1° vs 2° dengue). This pattern suggests progressive CSR accumulation across the DENV-specific compartment with repeat infections (see Singh2026 - DENV-Specific Memory B Cell Subsets, n=58 samples, 18 patients).

  • IgG dominance with minimal IgM confirms CSR completion in dengue plasmablasts: In predominantly secondary dengue (42/46), ELISpot showed ≥70% of all IgG-secreting plasmablasts were DENV-specific, with IgA ~100-fold lower and IgM near-absent. The overwhelming IgG:IgM ratio in secondary infections confirms that class switch recombination was completed before or during the plasmablast burst. Primary responders (n=4) retained detectable IgM, consistent with ongoing CSR during the first encounter (see Wrammert2012 - Plasmablast Responses in Acute Dengue, ELISpot, n=46 cohort).

  • IgG-dominant PBs vs. IgM-enriched DENV-binding MBCs — CSR segregates the two compartments: In Appanna2016, plasmablasts were overwhelmingly IgG-expressing in both primary and secondary infection, while DENV-binding MBCs contained a disproportionately large IgM fraction. Non-DENV-binding MBCs were IgG-dominant, matching the PB isotype profile. The CSR status thus distinguishes the two DENV-binding B cell compartments: PBs are class-switched (IgG), while a substantial fraction of the antigen-specific MBC pool retains IgM. The IgM⁺ DENV-binding MBCs may represent germline-encoded polyreactive binders or GC-independent IgM memory (see Appanna2016 - Plasmablasts as Subset of Memory B Cell Pool, 454 + Sanger, n=12 dengue).

  • CSR decoupled from SHM in acute dengue — direct evidence for T-independent class switching: GodoyLozano2016 observed IgG class-switched B cells with near-germline VH mutation levels during acute dengue. The paradox of IgG expression (requiring CSR) with low SHM (suggesting no GC transit) is the molecular hallmark of T-independent CSR. The authors propose that TLR7-mediated endosomal DENV recognition synergises with BCR signalling to drive AID expression and CSR independently of CD40–CD154 T cell help, analogous to the BLyS/APRIL mechanism described in Wei2007. This provides the first dengue-specific evidence that CSR and SHM are functionally uncoupled during acute infection (see GodoyLozano2016 - Lower IgG SHM Rates in Acute Dengue, n=19 acute dengue, 454 pyrosequencing of IgG VH cDNA).

  • IgG dominance confirmed by mAb cloning in secondary dengue: All 53 mAbs generated from single-cell sorted plasmablasts in Priyamvada2016 were IgG, with ELISpot showing 36–95% of IgG ASCs were DENV-specific. The completeness of CSR in secondary dengue PBs is consistent with memory B cell recall (prior GC-mediated CSR) rather than de novo switching during the acute response (see Priyamvada2016 - Cross-Reactive Memory Plasmablasts in Secondary Dengue, n=4 secondary DHF, single-cell mAb cloning).

  • The ABC/atypical population is predominantly class-switched, but retains an unswitched fraction. Most ABCs are class-switched (predominantly IgG or IgA), yet scRNA-seq shows the population also contains unswitched IgD⁺ cells — and those IgD⁺ ABCs are themselves antigen-experienced (SHM⁺, clonally related to IgD⁻ cells). CSR is part of the TLR7/9 + IFN-γ/IL-21 ABC differentiation programme, reinforcing that switched isotypes arise across the GC-independent atypical compartment (see Lamprinou2026 - ABCs and DN B Cells, opinion, citing Ambegaonkar 2022 / Maul 2021; Age-Associated B Cell).

  • ★ CSR occurs primarily BEFORE germinal-center entry — switching is not evidence of GC transit. The long-standing use of class-switch status as an indirect marker of GC participation rested on the assumption that CSR happens predominantly within GCs. Newer work indicates CSR takes place primarily prior to GC entry, with switched cells then gaining a competitive advantage inside the GC and thereby becoming enriched over the course of the reaction (see Glaros2025 - Multilayered Identity of B Cell Memory, review, no original data). Switching is therefore a pre-GC event whose products are selected in GCs — the enrichment is real, the inference from it is not.

  • Fate mapping confirms the proxy fails in both directions. GC-specific fate mapping shows that GC-independent early MBCs include a significant fraction of class-switched cells, while GC-derived MBCs can remain IgM⁺ or even IgM⁺IgD⁺. The review’s conclusion is that class-switch status “is insufficient to definitively discriminate” the two subsets, and that even the IgD⁺ compartment contains antigen-experienced cells of both GC and non-GC origin (review, mouse). Wiki consequence: the isotype-fate segregation model (Bhattacharya2016 - Memory B Cell Subset Selection in Secondary Dengue, citing Seifert 2015) remains useful as a fate-bias model — IgG⁺ memory→PB, IgM⁺ memory→GC reentry — but should not be read as an origin model.

  • AID activity outside GCs undermines Aicda-based origin inference. Many tissue-resident memory B cell studies infer GC origin from Aicda-based fate mapping, but because AID-driven CSR and SHM also occur outside the GC, these systems do not definitively establish GC provenance (review). See Tissue-Resident Memory B Cell and, for the wiki’s existing statements of the same principle, William2002 - Extrafollicular Somatic Hypermutation in Autoimmune Mice and Kaneko2020 - GC Loss and TFH Block in COVID-19.

  • Tissue context dictates switched isotype. After respiratory infection the lung resident-memory pool is predominantly IgA⁺ with a smaller IgG⁺ fraction, and IgA⁺ memory localizes to lung parenchyma alongside IgA-secreting PCs and iBALT; systemic immunization fails to induce lung IgA⁺ memory whereas intranasal immunization does. Skin-associated B cells within S. epidermidis-induced dermal tertiary lymphoid structures switch locally to IgG2b/IgG2c (see Glaros2025 - Multilayered Identity of B Cell Memory, review, mouse). CSR outcome is therefore set by anatomical niche, not only by cytokine milieu.

  • ABCs comprise both switched and unswitched cells, with isotype skewing toward IgG2a/c in mice and IgG1 in humans — and an open progenitor question. Hao-defined ABCs include IgM⁻ (switched) and IgM⁺ (largely unswitched) cells; a speculative mapping assigns switched (IgM⁻IgD⁻) and unswitched (IgM⁺IgD⁻) cells to antigen-driven memory, versus homeostatically expanded primary cells (IgM⁺IgD⁺). Effector isotype is skewed toward IgG2a/c in mice and IgG1 in humans, favouring inflammatory effector function including ADCC (see Cancro2020 - Age-Associated B Cells, review — no original data; mouse + human). Open question, explicitly unresolved: are unswitched, unmutated IgM⁺ ABCs the progenitors of class-switched, mutated ABCs, or are these stable parallel pools?

  • [2026-08-27] IgG4 class switching in IgG4-related disease is attributed to pre-GC Tfh help acting outside germinal centres. The framing of Allard-Chamard2023 - DN3 B Cells Infiltrate Inflamed Tissues — background from the same group’s earlier work, not data reported in that paper — is that switching to IgG4 is driven by IL-4- and IL-10-expressing pre-GC T follicular helper cells outside germinal centres. What the paper does contribute is the cellular correlate: DN3 B cells were the only B cell subset transcriptomically enriched for IGHG4 (n=4 bulk RNA-seq). This is the wiki’s only isotype-to-DN-subset link, and it points to a GC-independent route to a specific isotype (see Allard-Chamard2023 - DN3 B Cells Infiltrate Inflamed Tissues, n=4; introduction cites Maehara 2018 / Munemura 2022, neither ingested). See IgG, GC-Independent Response.

  • In Sanz2019’s canonical table, switching does not separate the DN subsets — activation state does. DN1 and DN2 are both annotated IgM/IgG/IgA⁺ (the FcRL4⁺ atypical/tissue-based DN row carries no isotype annotation); what distinguishes them is CD38/CD24/CD21 plus CXCR5, CD11c, FCRL5 and FcRL4. Isotype is listed among the additional rather than core markers. The practical consequence for this wiki: a switched isotype within the DN gate is not by itself evidence about which DN subset, or which pathway, produced the cell (see Sanz2019 - Consistent Classification of Human B Cell Populations, review — no original data).

  • T-bet directs IgG2c switching but IgG2b escapes the requirement — an isotype-selective dependency. In μMT bone-marrow chimeras, B-cell-intrinsic T-bet deletion abolished NP-specific IgG2c antibody and IgG2c⁺ memory B cells after influenza, while NP-specific IgG2b antibody and IgG2b⁺ memory B cells were intact; IgG1 and Hp-specific responses were also unaffected (see Stone2019 - T-bet Promotes ASC Differentiation by Limiting IFN-gamma Inflammation, mouse, n=5–8/group). The authors attribute the IgG2b escape to TGF-β, which drives IgG2b switching and potently suppresses IFN-γ signalling — so IgG2b⁺ cells may be unable to respond to IFN-γ and switch/differentiate T-bet-independently. CSR requirements are therefore cytokine-pathway-specific rather than uniform across the IgG subclasses, which is worth holding when reading subclass distributions as a pathway readout.

  • ★ CSR proceeds to the same extent outside the germinal centre as inside it — measured in fate-mapped cells. Full-length Ig sequencing with UMIs (~248,116 high-quality assembled reads per sample, n=3 mice) found isotype usage of GC-independent T-bet⁺CD11c⁺ B cells not different from GC B cells — ~80% of GC sequences IgG, with the T-bet⁺CD11c⁺ population predominantly IgG2b/IgG2c. Affinity maturation in the same cells was clearly reduced (mutation load 0.64% vs 0.99%; CDR replacement 0.66% vs 1.21%), so the study dissociates switching from maturation: the germinal centre is needed for one and not the other. The authors attribute switching to transient, CD40L-dependent Tfh induction of AID followed by rapid Aicda downregulation (see Song2022 - Tfh Outside Germinal Centers Drive T-bet CD11c B Cells, mouse, LCMV-Armstrong).

Contradictions & Debates

  • TLR7-mediated vs. Tph-mediated CSR in dengue: GodoyLozano2016 proposes T-independent CSR via TLR7-mediated endosomal DENV recognition, while Ansari2025 demonstrates Tph-dependent B cell help via IL-21. Whether CSR in acute dengue is driven by TLR7-autonomous B cell activation, T cell help (Tph→IL-21), or both concurrently is unresolved.
  • Woodruff2020 n=1 scV(D)J evidence for ongoing EF CSR: The strongest direct evidence for real-time CSR in EF-derived ASCs comes from a single COVID-19 patient’s repertoire — insufficient to establish generalizability. Whether ongoing CSR occurs in the dengue EF-derived plasmablast pool has not been tested.

Double-Negative B Cell, DN2 B Cell, Age-Associated B Cell, Plasmablast, Germinal Center, Extrafollicular Response, Somatic Hypermutation, IgG, IgA, IgM, Memory B Cell, Original Antigenic Sin, Early Memory B Cell, Tissue-Resident Memory B Cell, GC-Independent Response

Sources

Graph View

Backlinks